[HTML][HTML] Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different …
E Roux, K Abeti, D Speiser, C Helg, B Chapuis… - Blood, 1993 - Elsevier
We have characterized mixed chimerism (MC) in five patients with chronic myeloid leukemia
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
(CML) who received transplants with T-cell—depleted bone marrow (BM) and who relapsed …
Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with …
A Lassaletta, M Ramirez, JM Montero… - Leukemia, 2005 - nature.com
Despite the many reports available on chimerism status after allogeneic hematopoietic
transplantation, few studies have focused on chimerism using peripheral blood progenitor …
transplantation, few studies have focused on chimerism using peripheral blood progenitor …
Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse
A Schattenberg, T De Witte, M Salden, J Vet, B Van Dijk… - 1989 - ashpublications.org
Using red cell phenotyping, cytogenetic analysis of blood lymphocytes, chromosome studies
of bone marrow cells, and restriction fragment length polymorphism (RFLP) studies of …
of bone marrow cells, and restriction fragment length polymorphism (RFLP) studies of …
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia
L Hambach, M Eder, E Dammann, K Battmer… - Bone marrow …, 2001 - nature.com
We report a patient with Ph-positive CML who developed a Ph-negative AML in donor cells
14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation …
14 months after BMT from an HLA-identical male unrelated donor. The Ph translocation …
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
S Piemontese, A Boumendil, M Labopin… - Journal of Hematology & …, 2019 - Springer
Background As information on incidence, risk factors, and outcome of acute leukemia (AL)
relapse after unmanipulated haploidentical stem cell transplantation (haplo-SCT) is scarce …
relapse after unmanipulated haploidentical stem cell transplantation (haplo-SCT) is scarce …
Leukemia: management of relapse after allogeneic bone marrow transplantation.
L Kumar - Journal of clinical oncology, 1994 - ascopubs.org
PURPOSE To review the current state of knowledge regarding the management of leukemic
relapse after allogeneic bone marrow transplantation (BMT). PATIENTS AND METHODS …
relapse after allogeneic bone marrow transplantation (BMT). PATIENTS AND METHODS …
Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow …
MC Rapanotti, W Arcese, S Buffolino, AP Iori… - Bone marrow …, 1997 - nature.com
Recent observations of chimerism in patients relapsed following an allotransplant suggest
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …
the persistence of immunotolerance, thus offering a biologic rationale for the use of donor …
Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients
J Mehta, R Powles, S Kulkarni, J Treleaven… - Bone Marrow …, 1997 - nature.com
Thirty-two adults (median age 36 years) with leukemia (15 AML, eight CML, six ALL, three
CLL) persisting or relapsing 1–40 months (median 4) after allogeneic BMT (20 matched …
CLL) persisting or relapsing 1–40 months (median 4) after allogeneic BMT (20 matched …
[HTML][HTML] Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia …
S Lee, BS Cho, SY Kim, SM Choi, DG Lee… - Biology of Blood and …, 2007 - Elsevier
The aim of the present study was to identify graft-versus-leukemia effects and the factors that
affect outcome in 201 adults with acute lymphobalstic leukemia who received myeloablative …
affect outcome in 201 adults with acute lymphobalstic leukemia who received myeloablative …
Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a …
E Gorczynska, D Turkiewicz, J Toporski… - Bone marrow …, 2004 - nature.com
Immunotherapy consisting of withdrawal of immunosuppression and/or donor lymphocyte
infusions was initiated in 14 children (10 acute lymphoblastic leukemia, three acute …
infusions was initiated in 14 children (10 acute lymphoblastic leukemia, three acute …